Clinical trial
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00448370 |
|---|---|
| Title | Role of Placenta Growth Factor in Sickle Acute Chest Syndrome |
| Official title | Role of Placenta Growth Factor in Sickle Acute Chest Syndrome |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Anemia, Sickle Cell |
| Enrollment | 136 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2012 |
| First posted | Mar 16, 2007 |
| Last update posted | Dec 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: